-+ 0.00%
-+ 0.00%
-+ 0.00%

*Rhythm Pharmaceuticals Announces MHLW Approval Of IMCIVREE(R) (setmelanotide) For Patients With Acquired Hypothalamic Obesity (HO) In Japan >RYTM

Dow Jones·08/24/2026 12:01:00

Please log in to view news